Albumin concentrations showed a similar declining trend, with significantly reduced values in the oral cancer group (3.43 ± 0.47 g/dL) compared to the precancerous (3.84 ± 0.47 g/dL) and control groups (4.00 ± 0.32 g/dL) (p = 0.001). The gene discussed is ALB; the disease is lip and oral cavity carcinoma.